Sara Zaknoen

Title: Sara Zaknoen: Innovator in Cancer Treatment

Introduction

Sara Zaknoen is a prominent inventor based in Hoboken, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. Her work focuses on combination therapies that aim to improve patient outcomes in the fight against proliferative diseases.

Latest Patents

Sara Zaknoen holds a patent for "Combinations of therapeutic agents for treating cancer." This patent discloses a combination therapy designed for patients suffering from diseases associated with persistent angiogenesis. The treatment involves the use of a camptothecin derivative alongside various chemotherapeutic agents, including microtubule active agents, alkylating agents, and several inhibitors targeting different pathways involved in cancer progression. This innovative approach aims to enhance the efficacy of cancer treatments and provide new hope for patients.

Career Highlights

Throughout her career, Sara has worked with notable companies in the pharmaceutical industry, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Novartis AG. Her experience in these organizations has allowed her to collaborate with leading experts and contribute to groundbreaking research in cancer therapies.

Collaborations

Sara has collaborated with esteemed colleagues, including Margaret Ma Woo and Richard William Versace. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment.

Conclusion

Sara Zaknoen's innovative work in developing combination therapies for cancer treatment highlights her dedication to improving patient care. Her contributions to the field are invaluable, and her patent reflects her commitment to advancing medical science.